AB toxins enter a host cell by receptor-mediated endocytosis. The catalytic A chain then crosses the endosome or endoplasmic reticulum (ER) membrane to reach its cytosolic target. Dissociation of the A chain from the cell-binding B chain occurs before or during translocation to the cytosol, and only the A chain enters the cytosol. In some cases, AB subunit dissociation is facilitated by the unique physiology and function of the ER. The A chains of these ER-translocating toxins are stable within the architecture of the AB holotoxin, but toxin disassembly results in spontaneous or assisted unfolding of the isolated A chain. This unfolding event places the A chain in a translocation-competent conformation that promotes its export to the cytosol through the quality control mechanism of ER-associated degradation. A lack of lysine residues for ubiquitin conjugation protects the exported A chain from degradation by the ubiquitin-proteasome system, and an interaction with host factors allows the cytosolic toxin to regain a folded, active state. The intrinsic instability of the toxin A chain thus influences multiple steps of the intoxication process. This review will focus on the host–toxin interactions involved with A chain unfolding in the ER and A chain refolding in the cytosol.
References
[1]
Barth, H. Exploring the role of host cell chaperones/PPIases during cellular up-take of bacterial ADP-ribosylating toxins as basis for novel pharmacological strategies to protect mammalian cells against these virulence factors. Naunyn. Schmiedebergs. Arch. Pharmacol. 2011, 383, 237–245, doi:10.1007/s00210-010-0581-y.
[2]
Sandvig, K.; van Deurs, B. Membrane traffic exploited by protein toxins. Annu. Rev. Cell Dev. Biol. 2002, 18, 1–24, doi:10.1146/annurev.cellbio.18.011502.142107.
Wernick, N.L.B.; Chinnapen, D.J.-F.; Cho, J.A.; Lencer, W.I. Cholera toxin: an intracellular journey into the cytosol by way of the endoplasmic reticulum. Toxins 2010, 2, 310–325, doi:10.3390/toxins2030310.
[5]
Lord, J.M.; Spooner, R.A. Ricin trafficking in plant and mammalian cells. Toxins 2011, 3, 787–801, doi:10.3390/toxins3070787.
[6]
Carbonetti, N.H. Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol. 2010, 5, 455–469, doi:10.2217/fmb.09.133.
[7]
Torgersen, M.L.; Engedal, N.; Bergan, J.; Sandvig, K. The intracellular journey of Shiga toxins. Open. Toxinol. J. 2010, 3, 3–12, doi:10.2174/1875414701003020003.
[8]
Ampapathi, R.S.; Creath, A.L.; Lou, D.I.; Craft, J.W., Jr.; Blanke, S.R.; Legge, G.B. Order-disorder-order transitions mediate the activation of cholera toxin. J. Mol. Biol. 2008, 377, 748–760, doi:10.1016/j.jmb.2007.12.075.
[9]
Lencer, W.I.; de Almeida, J.B.; Moe, S.; Stow, J.L.; Ausiello, D.A.; Madara, J.L. Entry of cholera toxin into polarized human intestinal epithelial cells. Identification of an early brefeldin A sensitive event required for A1-peptide generation. J. Clin. Invest. 1993, 92, 2941–2951, doi:10.1172/JCI116917.
[10]
Sandvig, K.; Prydz, K.; Ryd, M.; van Deurs, B. Endocytosis and intracellular transport of the glycolipid-binding ligand Shiga toxin in polarized MDCK cells. J. Cell Biol. 1991, 113, 553–562, doi:10.1083/jcb.113.3.553.
[11]
Johannes, L.; Tenza, D.; Antony, C.; Goud, B. Retrograde transport of KDEL-bearing B-fragment of Shiga toxin. J. Biol. Chem. 1997, 272, 19554–19561, doi:10.1074/jbc.272.31.19554.
[12]
Orlandi, P.A.; Curran, P.K.; Fishman, P.H. Brefeldin A blocks the response of cultured cells to cholera toxin. Implications for intracellular trafficking in toxin action. J. Biol. Chem. 1993, 268, 12010–12016.
[13]
Sandvig, K.; Prydz, K.; Hansen, S.H.; van Deurs, B. Ricin transport in brefeldin A-treated cells: correlation between Golgi structure and toxic effect. J. Cell Biol. 1991, 115, 971–981, doi:10.1083/jcb.115.4.971.
[14]
van Deurs, B.; Sandvig, K.; Petersen, O.W.; Olsnes, S.; Simons, K.; Griffiths, G. Estimation of the amount of internalized ricin that reaches the trans-Golgi network. J. Cell Biol. 1988, 106, 253–267, doi:10.1083/jcb.106.2.253.
[15]
el Baya, A.; Linnemann, R.; von Olleschik-Elbheim, L.; Robenek, H.; Schmidt, M.A. Endocytosis and retrograde transport of pertussis toxin to the Golgi complex as a prerequisite for cellular intoxication. Eur. J. Cell Biol. 1997, 73, 40–48.
[16]
Plaut, R.D.; Carbonetti, N.H. Retrograde transport of pertussis toxin in the mammalian cell. Cell. Microbiol. 2008, 10, 1130–1139, doi:10.1111/j.1462-5822.2007.01115.x.
[17]
Pasetto, M.; Barison, E.; Castagna, M.; Della Cristina, P.; Anselmi, C.; Colombatti, M. Reductive activation of type 2 ribosome-inactivating proteins is promoted by transmembrane thioredoxin-related protein. J. Biol. Chem. 2012, 287, 7367–7373, doi:10.1074/jbc.M111.316828.
[18]
Bellisola, G.; Fracasso, G.; Ippoliti, R.; Menestrina, G.; Rosen, A.; Solda, S.; Udali, S.; Tomazzolli, R.; Tridente, G.; Colombatti, M. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase. Biochem. Pharmacol. 2004, 67, 1721–1731, doi:10.1016/j.bcp.2004.01.013.
[19]
Spooner, R.A.; Watson, P.D.; Marsden, C.J.; Smith, D.C.; Moore, K.A.; Cook, J.P.; Lord, J.M.; Roberts, L.M. Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum. Biochem. J. 2004, 383, 285–293, doi:10.1042/BJ20040742.
[20]
O'Hara, J.M.; Mantis, N.J. Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro. J. Immunol. Methods 2013, 395, 71–78, doi:10.1016/j.jim.2013.06.004.
[21]
Majoul, I.; Ferrari, D.; Soling, H.D. Reduction of protein disulfide bonds in an oxidizing environment. The disulfide bridge of cholera toxin A-subunit is reduced in the endoplasmic reticulum. FEBS Lett. 1997, 401, 104–108, doi:10.1016/S0014-5793(96)01447-0.
[22]
Orlandi, P.A. Protein-disulfide isomerase-mediated reduction of the A subunit of cholera toxin in a human intestinal cell line. J. Biol. Chem. 1997, 272, 4591–4599.
[23]
Mekalanos, J.J.; Collier, R.J.; Romig, W.R. Enzymic activity of cholera toxin. II. Relationships to proteolytic processing, disulfide bond reduction, and subunit composition. J. Biol. Chem. 1979, 254, 5855–5861.
[24]
Mekalanos, J.J.; Collier, R.J.; Romig, W.R. Purification of cholera toxin and its subunits: new methods of preparation and the use of hypertoxinogenic mutants. Infect. Immun. 1978, 20, 552–558.
[25]
Tomasi, M.; Battistini, A.; Araco, A.; Roda, L.G.; D'Agnolo, G. The role of the reactive disulfide bond in the interaction of cholera-toxin functional regions. Eur. J. Biochem. 1979, 93, 621–627, doi:10.1111/j.1432-1033.1979.tb12862.x.
[26]
Taylor, M.; Banerjee, T.; Ray, S.; Tatulian, S.A.; Teter, K. Protein disulfide isomerase displaces the cholera toxin A1 subunit from the holotoxin without unfolding the A1 subunit. J. Biol. Chem. 2011, 286, 22090–22100, doi:10.1074/jbc.M111.237966.
[27]
Tsai, B.; Rodighiero, C.; Lencer, W.I.; Rapoport, T.A. Protein disulfide isomerase acts as a redox-dependent chaperone to unfold cholera toxin. Cell 2001, 104, 937–948, doi:10.1016/S0092-8674(01)00289-6.
[28]
Forster, M.L.; Sivick, K.; Park, Y.N.; Arvan, P.; Lencer, W.I.; Tsai, B. Protein disulfide isomerase-like proteins play opposing roles during retrotranslocation. J. Cell Biol. 2006, 173, 853–859, doi:10.1083/jcb.200602046.
[29]
Taylor, M.; Burress, H.; Banerjee, T.; Ray, S.; Curtis, D.; Tatulian, S.A.; Teter, K. Substrate-induced unfolding of protein disulfide isomerase displaces the cholera toxin A1 subunit from its holotoxinSubmitted for publication.
[30]
Gilbert, J.; Ou, W.; Silver, J.; Benjamin, T. Downregulation of protein disulfide isomerase inhibits infection by the mouse polyomavirus. J. Virol. 2006, 80, 10868–10870, doi:10.1128/JVI.01117-06.
[31]
Ou, W.; Silver, J. Role of protein disulfide isomerase and other thiol-reactive proteins in HIV-1 envelope protein-mediated fusion. Virology 2006, 350, 406–417, doi:10.1016/j.virol.2006.01.041.
Fraser, M.E.; Chernaia, M.M.; Kozlov, Y.V.; James, M.N. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution. Nat. Struct. Biol. 1994, 1, 59–64, doi:10.1038/nsb0194-59.
[37]
Wedekind, J.E.; Trame, C.B.; Dorywalska, M.; Koehl, P.; Raschke, T.M.; McKee, M.; FitzGerald, D.; Collier, R.J.; McKay, D.B. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity. J. Mol. Biol. 2001, 314, 823–837, doi:10.1006/jmbi.2001.5195.
[38]
Nesic, D.; Hsu, Y.; Stebbins, C.E. Assembly and function of a bacterial genotoxin. Nature 2004, 429, 429–433, doi:10.1038/nature02532.
[39]
Burns, D.L.; Manclark, C.R. Adenine nucleotides promote dissociation of pertussis toxin subunits. J. Biol. Chem. 1986, 261, 4324–4327.
[40]
Hazes, B.; Boodhoo, A.; Cockle, S.A.; Read, R.J. Crystal structure of the pertussis toxin-ATP complex: a molecular sensor. J. Mol. Biol. 1996, 258, 661–671, doi:10.1006/jmbi.1996.0277.
[41]
Moss, J.; Stanley, S.J.; Watkins, P.A.; Burns, D.L.; Manclark, C.R.; Kaslow, H.R.; Hewlett, E.L. Stimulation of the thiol-dependent ADP-ribosyltransferase and NAD glycohydrolase activities of Bordetella pertussis toxin by adenine nucleotides, phospholipids, and detergents. Biochemistry 1986, 25, 2720–2725, doi:10.1021/bi00357a066.
[42]
Braakman, I.; Helenius, J.; Helenius, A. Role of ATP and disulphide bonds during protein folding in the endoplasmic reticulum. Nature 1992, 356, 260–262, doi:10.1038/356260a0.
[43]
Clairmont, C.A.; De Maio, A.; Hirschberg, C.B. Translocation of ATP into the lumen of rough endoplasmic reticulum-derived vesicles and its binding to luminal proteins including BiP (GRP 78) and GRP 94. J. Biol. Chem. 1992, 267, 3983–3990.
[44]
Moss, J.; Stanley, S.J.; Burns, D.L.; Hsia, J.A.; Yost, D.A.; Myers, G.A.; Hewlett, E.L. Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). J. Biol. Chem. 1983, 258, 11879–11882.
[45]
Olsnes, S.; Reisbig, R.; Eiklid, K. Subunit structure of Shigella cytotoxin. J. Biol. Chem. 1981, 256, 8732–8738.
[46]
Garred, O.; van Deurs, B.; Sandvig, K. Furin-induced cleavage and activation of Shiga toxin. J. Biol. Chem. 1995, 270, 10817–10821, doi:10.1074/jbc.270.18.10817.
[47]
Garred, O.; Dubinina, E.; Polesskaya, A.; Olsnes, S.; Kozlov, J.; Sandvig, K. Role of the disulfide bond in Shiga toxin A-chain for toxin entry into cells. J. Biol. Chem. 1997, 272, 11414–11419, doi:10.1074/jbc.272.17.11414.
[48]
Weldon, J.E.; Pastan, I. A guide to taming a toxin--recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer. FEBS J. 2011, 278, 4683–4700, doi:10.1111/j.1742-4658.2011.08182.x.
[49]
McKee, M.L.; FitzGerald, D.J. Reduction of furin-nicked Pseudomonas exotoxin A: an unfolding story. Biochemistry 1999, 38, 16507–16513, doi:10.1021/bi991308+.
[50]
Ogata, M.; Chaudhary, V.K.; Pastan, I.; FitzGerald, D.J. Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol. J. Biol. Chem. 1990, 265, 20678–20685.
[51]
Allured, V.S.; Collier, R.J.; Carroll, S.F.; McKay, D.B. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution. Proc. Natl. Acad. Sci. USA 1986, 83, 1320–1324, doi:10.1073/pnas.83.5.1320.
[52]
Leppla, S.H.; Martin, O.C.; Muehl, L.A. The exotoxin P. aeruginosa: a proenzyme having an unusual mode of activation. Biochem. Biophys. Res. Commun. 1978, 81, 532–538, doi:10.1016/0006-291X(78)91567-X.
[53]
Bilge, A.; Howell-Clark, J.; Ramakrishnan, S.; Press, O.W. Degradation of ricin A chain by endosomal and lysosomal enzymes--the protective role of ricin B chain. Ther. Immunol. 1994, 1, 197–204.
[54]
Norton, E.B.; Lawson, L.B.; Mahdi, Z.; Freytag, L.C.; Clements, J.D. The A Subunit of Escherichia coli Heat-Labile Enterotoxin Functions as a Mucosal Adjuvant and Promotes IgG2a, IgA, and Th17 Responses to Vaccine Antigens. Infect. Immun. 2012, 80, 2426–2435, doi:10.1128/IAI.00181-12.
[55]
Kim, S.H.; Ryu, S.H.; Lee, S.H.; Lee, Y.H.; Lee, S.R.; Huh, J.W.; Kim, S.U.; Kim, E.; Kim, S.; Jon, S.; Bishop, R.E.; Chang, K.T. Instability of toxin A subunit of AB(5) toxins in the bacterial periplasm caused by deficiency of their cognate B subunits. Biochim. Biophys. Acta. 2011, 1808, 2359–2365, doi:10.1016/j.bbamem.2011.06.016.
[56]
Pande, A.H.; Scaglione, P.; Taylor, M.; Nemec, K.N.; Tuthill, S.; Moe, D.; Holmes, R.K.; Tatulian, S.A.; Teter, K. Conformational instability of the cholera toxin A1 polypeptide. J. Mol. Biol. 2007, 374, 1114–1128, doi:10.1016/j.jmb.2007.10.025.
[57]
Burns, D.L.; Hausman, S.Z.; Lindner, W.; Robey, F.A.; Manclark, C.R. Structural characterization of pertussis toxin A subunit. J. Biol. Chem. 1987, 262, 17677–17682.
[58]
Goins, B.; Freire, E. Thermal stability and intersubunit interactions of cholera toxin in solution and in association with its cell-surface receptor ganglioside GM1. Biochemistry 1988, 27, 2046–2052, doi:10.1021/bi00406a035.
[59]
Dalziel, A.W.; Lipka, G.; Chowdhry, B.Z.; Sturtevant, J.M.; Schafer, D.E. Effects of ganglioside GM1 on the thermotropic behavior of cholera toxin B subunit. Mol. Cell. Biochem. 1984, 63, 83–91.
[60]
Surewicz, W.K.; Leddy, J.J.; Mantsch, H.H. Structure, stability, and receptor interaction of cholera toxin as studied by Fourier-transform infrared spectroscopy. Biochemistry 1990, 29, 8106–8111, doi:10.1021/bi00487a017.
[61]
Bhakuni, V.; Xie, D.; Freire, E. Thermodynamic identification of stable folding intermediates in the B-subunit of cholera toxin. Biochemistry 1991, 30, 5055–5060, doi:10.1021/bi00234a031.
[62]
Winkeler, A.; Godderz, D.; Herzog, V.; Schmitz, A. BiP-dependent export of cholera toxin from endoplasmic reticulum-derived microsomes. FEBS Lett. 2003, 554, 439–442, doi:10.1016/S0014-5793(03)01217-1.
[63]
Banerjee, T.; Pande, A.; Jobling, M.G.; Taylor, M.; Massey, S.; Holmes, R.K.; Tatulian, S.A.; Teter, K. Contribution of subdomain structure to the thermal stability of the cholera toxin A1 subunit. Biochemistry 2010, 49, 8839–8846, doi:10.1021/bi101201c.
[64]
Taylor, M.; Banerjee, T.; Navarro-Garcia, F.; Huerta, J.; Massey, S.; Burlingame, M.; Pande, A.H.; Tatulian, S.A.; Teter, K. A therapeutic chemical chaperone inhibits cholera intoxication and unfolding/translocation of the cholera toxin A1 subunit. PLoS ONE 2011, 6, e18825, doi:10.1371/journal.pone.0018825.
[65]
Massey, S.; Banerjee, T.; Pande, A.H.; Taylor, M.; Tatulian, S.A.; Teter, K. Stabilization of the tertiary structure of the cholera toxin A1 subunit inhibits toxin dislocation and cellular intoxication. J. Mol. Biol. 2009, 393, 1083–1096, doi:10.1016/j.jmb.2009.09.013.
[66]
Gekko, K.; Timasheff, S.N. Mechanism of protein stabilization by glycerol: preferential hydration in glycerol-water mixtures. Biochemistry 1981, 20, 4667–4676, doi:10.1021/bi00519a023.
[67]
Vagenende, V.; Yap, M.G.; Trout, B.L. Mechanisms of protein stabilization and prevention of protein aggregation by glycerol. Biochemistry 2009, 48, 11084–11096, doi:10.1021/bi900649t.
[68]
Maestri, N.E.; Brusilow, S.W.; Clissold, D.B.; Bassett, S.S. Long-term treatment of girls with ornithine transcarbamylase deficiency. N. Engl. J. Med. 1996, 335, 855–859, doi:10.1056/NEJM199609193351204.
[69]
Jackson, L.S.; Tolleson, W.H.; Chirtel, S.J. Thermal Inactivation of Ricin Using Infant Formula as a Food Matrix. J. Agric. Food Chem. 2006, 54, 7300–7304, doi:10.1021/jf061199n.
[70]
Jackson, L.S.; Zhang, Z.; Tolleson, W.H. Thermal stability of ricin in orange and apple juices. J. Food Sci. 2010, 75, T65–T71, doi:10.1111/j.1750-3841.2010.01570.x.
[71]
Zhang, Z.; Triplett, O.A.; Nguyen, K.T.; Melchior, W.B., Jr.; Taylor, K.; Jackson, L.S.; Tolleson, W.H. Thermal inactivation reaction rates for ricin are influenced by pH and carbohydrates. Food Chem. Toxicol. 2013, 58, 116–123, doi:10.1016/j.fct.2013.04.012.
McHugh, C.A.; Tammariello, R.F.; Millard, C.B.; Carra, J.H. Improved stability of a protein vaccine through elimination of a partially unfolded state. Protein Sci. 2004, 13, 2736–2743.
[74]
Olson, M.A.; Carra, J.H.; Roxas-Duncan, V.; Wannemacher, R.W.; Smith, L.A.; Millard, C.B. Finding a new vaccine in the ricin protein fold. Protein Eng. Des. Sel. 2004, 17, 391–397, doi:10.1093/protein/gzh043.
[75]
Peek, L.J.; Brey, R.N.; Middaugh, C.R. A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine. J. Pharm. Sci. 2007, 96, 44–60.
[76]
Deeks, E.D.; Cook, J.P.; Day, P.J.; Smith, D.C.; Roberts, L.M.; Lord, J.M. The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol. Biochemistry 2002, 41, 3405–3413.
[77]
Spooner, R.A.; Hart, P.J.; Cook, J.P.; Pietroni, P.; Rogon, C.; Hohfeld, J.; Roberts, L.M.; Lord, J.M. Cytosolic chaperones influence the fate of a toxin dislocated from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 2008, 105, 17408–17413, doi:10.1073/pnas.0809013105.
[78]
Piatak, M.; Lane, J.A.; Laird, W.; Bjorn, M.J.; Wang, A.; Williams, M. Expression of soluble and fully functional ricin A chain in Escherichia coli is temperature-sensitive. J. Biol. Chem. 1988, 263, 4837–4843.
[79]
Day, P.J.; Pinheiro, T.J.; Roberts, L.M.; Lord, J.M. Binding of ricin A-chain to negatively charged phospholipid vesicles leads to protein structural changes and destabilizes the lipid bilayer. Biochemistry 2002, 41, 2836–2843, doi:10.1021/bi012012i.
[80]
Mayerhofer, P.U.; Cook, J.P.; Wahlman, J.; Pinheiro, T.T.; Moore, K.A.; Lord, J.M.; Johnson, A.E.; Roberts, L.M. Ricin A chain insertion into endoplasmic reticulum membranes is triggered by a temperature increase to 37°C. J. Biol. Chem. 2009, 284, 10232–10242, doi:10.1074/jbc.M808387200.
[81]
Spooner, R.A.; Lord, J.M. How ricin and Shiga toxin reach the cytosol of target cells: retrotranslocation from the endoplasmic reticulum. Curr. Top. Microbiol. Immunol. 2012, 357, 19–40.
[82]
Redmann, V.; Oresic, K.; Tortorella, L.L.; Cook, J.P.; Lord, M.; Tortorella, D. Dislocation of ricin toxin a chains in human cells utilizes selective cellular factors. J. Biol. Chem. 2011, 286, 21231–21238, doi:10.1074/jbc.M111.234708.
[83]
Simpson, J.C.; Lord, J.M.; Roberts, L.M. Point mutations in the hydrophobic C-terminal region of ricin A chain indicate that Pro250 plays a key role in membrane translocation. Eur. J. Biochem. 1995, 232, 458–463, doi:10.1111/j.1432-1033.1995.tb20831.x.
[84]
Simpson, J.C.; Roberts, L.M.; Lord, J.M. Catalytic and cytotoxic activities of recombinant ricin A chain mutants with charged residues added at the carboxyl terminus. Protein Expr. Purif. 1995, 6, 665–670, doi:10.1006/prep.1995.1087.
[85]
Yan, Q.; Li, X.P.; Tumer, N.E. N-glycosylation does not affect the catalytic activity of ricin a chain but stimulates cytotoxicity by promoting its transport out of the endoplasmic reticulum. Traffic 2012, 13, 1508–1521, doi:10.1111/j.1600-0854.2012.01404.x.
[86]
Li, X.P.; Baricevic, M.; Saidasan, H.; Tumer, N.E. Ribosome depurination is not sufficient for ricin-mediated cell death in Saccharomyces cerevisiae. Infect. Immun. 2007, 75, 417–428, doi:10.1128/IAI.01295-06.
[87]
Sokolowska, I.; Walchli, S.; Wegrzyn, G.; Sandvig, K.; Slominska-Wojewodzka, M. A single point mutation in ricin A-chain increases toxin degradation and inhibits EDEM1-dependent ER retrotranslocation. Biochem. J. 2011, 436, 371–385.
[88]
Argent, R.H.; Roberts, L.M.; Wales, R.; Robertus, J.D.; Lord, J.M. Introduction of a disulfide bond into ricin A chain decreases the cytotoxicity of the ricin holotoxin. J. Biol. Chem. 1994, 269, 26705–26710.
[89]
Ray, S.; Taylor, M.; Burlingame, M.; Tatulian, S.A.; Teter, K. Modulation of toxin stability by 4-phenylbutyric acid and negatively charged phospholipids. PLoS ONE 2011, 6, e23692.
[90]
Sandvig, K.; Madshus, I.H.; Olsnes, S. Dimethyl sulphoxide protects cells against polypeptide toxins and poliovirus. Biochem. J. 1984, 219, 935–940.
[91]
Guerra, L.; Nemec, K.N.; Massey, S.; Tatulian, S.A.; Thelestam, M.; Frisan, T.; Teter, K. A novel mode of translocation for cytolethal distending toxin. Biochim. Biophys. Acta 2009, 1793, 489–495, doi:10.1016/j.bbamcr.2008.11.017.
[92]
Wesche, J.; Rapak, A.; Olsnes, S. Dependence of ricin toxicity on translocation of the toxin A-chain from the endoplasmic reticulum to the cytosol. J. Biol. Chem. 1999, 274, 34443–34449, doi:10.1074/jbc.274.48.34443.
[93]
Sandvig, K.; Olsnes, S. Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles. J. Biol. Chem. 1982, 257, 7504–7513.
[94]
Krell, T.; Greco, F.; Nicolai, M.C.; Dubayle, J.; Renauld-Mongenie, G.; Poisson, N.; Bernard, I. The use of microcalorimetry to characterize tetanus neurotoxin, pertussis toxin and filamentous haemagglutinin. Biotechnol. Appl. Biochem. 2003, 38, 241–251, doi:10.1042/BA20030089.
[95]
Yang, J.; Mou, J.; Shao, Z. Structure and stability of pertussis toxin studied by in situ atomic force microscopy. FEBS Lett. 1994, 338, 89–92, doi:10.1016/0014-5793(94)80122-3.
[96]
Pande, A.H.; Moe, D.; Jamnadas, M.; Tatulian, S.A.; Teter, K. The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome. Biochemistry 2006, 45, 13734–13740.
[97]
Rasooly, R.; Do, P.M. Shiga toxin Stx2 is heat-stable and not inactivated by pasteurization. Int. J. Food Microbiol. 2010, 136, 290–294, doi:10.1016/j.ijfoodmicro.2009.10.005.
[98]
He, X.; Quinones, B.; McMahon, S.; Mandrell, R.E. A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli. Toxins 2012, 4, 487–504, doi:10.3390/toxins4070487.
[99]
Pina, D.G.; Gomez, J.; Villar, E.; Johannes, L.; Shnyrov, V.L. Thermodynamic analysis of the structural stability of the shiga toxin B-subunit. Biochemistry 2003, 42, 9498–9506, doi:10.1021/bi034591s.
[100]
Menikh, A.; Saleh, M.T.; Gariepy, J.; Boggs, J.M. Orientation in lipid bilayers of a synthetic peptide representing the C-terminus of the A1 domain of shiga toxin. A polarized ATR-FTIR study. Biochemistry 1997, 36, 15865–15872.
[101]
Saleh, M.T.; Ferguson, J.; Boggs, J.M.; Gariepy, J. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes. Biochemistry 1996, 35, 9325–9334, doi:10.1021/bi960177z.
[102]
Suhan, M.L.; Hovde, C.J. Disruption of an internal membrane-spanning region in Shiga toxin 1 reduces cytotoxicity. Infect. Immun. 1998, 66, 5252–5259.
[103]
LaPointe, P.; Wei, X.; Gariepy, J. A role for the protease-sensitive loop region of Shiga-like toxin 1 in the retrotranslocation of its A1 domain from the endoplasmic reticulum lumen. J. Biol. Chem. 2005, 280, 23310–23318, doi:10.1074/jbc.M414193200.
[104]
Quinones, B.; Massey, S.; Friedman, M.; Swimley, M.S.; Teter, K. Novel cell-based method to detect Shiga toxin 2 from Escherichia coli O157:H7 and inhibitors of toxin activity. Appl. Environ. Microbiol. 2009, 75, 1410–1416, doi:10.1128/AEM.02230-08.
[105]
Eiklid, K.; Olsnes, S. Entry of Shigella dysenteriae toxin into HeLa cells. Infect. Immun. 1983, 42, 771–777.
[106]
Davio, S.R.; Kienle, K.M.; Collins, B.E. Interdomain interactions in the chimeric protein toxin sCD4(178)-PE40: a differential scanning calorimetry (DSC) study. Pharm. Res. 1995, 12, 642–648, doi:10.1023/A:1016239004714.
[107]
Guerra, L.; Cortes-Bratti, X.; Guidi, R.; Frisan, T. The biology of the cytolethal distending toxins. Toxins 2011, 3, 172–190, doi:10.3390/toxins3030172.
[108]
Gargi, A.; Reno, M.; Blanke, S.R. Bacterial toxin modulation of the eukaryotic cell cycle: are all cytolethal distending toxins created equally? Front. Cell. Infect. Microbiol. 2012, 2, 124, doi:10.3389/fcimb.2012.00124.
[109]
Guerra, L.; Teter, K.; Lilley, B.N.; Stenerlow, B.; Holmes, R.K.; Ploegh, H.L.; Sandvig, K.; Thelestam, M.; Frisan, T. Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell. Microbiol. 2005, 7, 921–934, doi:10.1111/j.1462-5822.2005.00520.x.
[110]
Needham, P.G.; Brodsky, J.L. How early studies on secreted and membrane protein quality control gave rise to the ER associated degradation (ERAD) pathway: The early history of ERAD. Biochim. Biophys. Acta 2013, 1833, 2447–2457, doi:10.1016/j.bbamcr.2013.03.018.
[111]
Brodsky, J.L. The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation). Biochem. J. 2007, 404, 353–363, doi:10.1042/BJ20061890.
[112]
Romisch, K. Surfing the Sec61 channel: bidirectional protein translocation across the ER membrane. J. Cell Sci. 1999, 112, 4185–4191.
[113]
Smith, M.H.; Ploegh, H.L.; Weissman, J.S. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science 2011, 334, 1086–1090, doi:10.1126/science.1209235.
[114]
Teter, K.; Holmes, R.K. Inhibition of endoplasmic reticulum-associated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin. Infect. Immun. 2002, 70, 6172–6179, doi:10.1128/IAI.70.11.6172-6179.2002.
[115]
Teter, K.; Jobling, M.G.; Holmes, R.K. A class of mutant CHO cells resistant to cholera toxin rapidly degrades the catalytic polypeptide of cholera toxin and exhibits increased endoplasmic reticulum-associated degradation. Traffic 2003, 4, 232–242, doi:10.1034/j.1600-0854.2003.00070.x.
[116]
Massey, S.; Burress, H.; Taylor, M.; Nemec, K.N.; Ray, S.; Haslam, D.B.; Teter, K. Structural and functional interactions between the cholera toxin A1 subunit and ERdj3/HEDJ, a chaperone of the endoplasmic reticulum. Infect. Immun. 2011, 79, 4739–4747, doi:10.1128/IAI.05503-11.
Jin, Y.; Awad, W.; Petrova, K.; Hendershot, L.M. Regulated release of ERdj3 from unfolded proteins by BiP. EMBO J. 2008, 27, 2873–2882, doi:10.1038/emboj.2008.207.
[119]
Shen, Y.; Hendershot, L.M. ERdj3, a Stress-inducible Endoplasmic Reticulum DnaJ Homologue, Serves as a CoFactor for BiP's Interactions with Unfolded Substrates. Mol. Biol. Cell 2005, 16, 40–50, doi:10.1091/mbc.E04-05-0434.
[120]
Schmitz, A.; Herrgen, H.; Winkeler, A.; Herzog, V. Cholera toxin is exported from microsomes by the Sec61p complex. J. Cell Biol. 2000, 148, 1203–1212, doi:10.1083/jcb.148.6.1203.
[121]
Bernardi, K.M.; Forster, M.L.; Lencer, W.I.; Tsai, B. Derlin-1 facilitates the retro-translocation of cholera toxin. Mol. Biol. Cell 2008, 19, 877–884.
[122]
Bernardi, K.M.; Williams, J.M.; Kikkert, M.; van Voorden, S.; Wiertz, E.J.; Ye, Y.; Tsai, B. The E3 ubiquitin ligases Hrd1 and gp78 bind to and promote cholera toxin retro-translocation. Mol. Biol. Cell 2010, 21, 140–151, doi:10.1091/mbc.E09-07-0586.
[123]
Dixit, G.; Mikoryak, C.; Hayslett, T.; Bhat, A.; Draper, R.K. Cholera toxin up-regulates endoplasmic reticulum proteins that correlate with sensitivity to the toxin. Exp. Biol. Med. (Maywood) 2008, 233, 163–175, doi:10.3181/0705-RM-132.
[124]
Saslowsky, D.E.; Cho, J.A.; Chinnapen, H.; Massol, R.H.; Chinnapen, D.J.; Wagner, J.S.; De Luca, H.E.; Kam, W.; Paw, B.H.; Lencer, W.I. Intoxication of zebrafish and mammalian cells by cholera toxin depends on the flotillin/reggie proteins but not Derlin-1 or -2. J. Clin. Invest. 2010, 120, 4399–4409, doi:10.1172/JCI42958.
[125]
Slominska-Wojewodzka, M.; Gregers, T.F.; Walchli, S.; Sandvig, K. EDEM is involved in retrotranslocation of ricin from the endoplasmic reticulum to the cytosol. Mol. Biol. Cell 2006, 17, 1664–1675, doi:10.1091/mbc.E05-10-0961.
[126]
Kanehara, K.; Kawaguchi, S.; Ng, D.T. The EDEM and Yos9p families of lectin-like ERAD factors. Semin. Cell Dev. Biol. 2007, 18, 743–750, doi:10.1016/j.semcdb.2007.09.007.
[127]
Taylor, M.; Navarro-Garcia, F.; Huerta, J.; Burress, H.; Massey, S.; Ireton, K.; Teter, K. Hsp90 is required for transfer of the cholera toxin A1 subunit from the endoplasmic reticulum to the cytosol. J. Biol. Chem. 2010, 285, 31261–31267, doi:10.1074/jbc.M110.148981.
Simpson, J.C.; Roberts, L.M.; Romisch, K.; Davey, J.; Wolf, D.H.; Lord, J.M. Ricin A chain utilises the endoplasmic reticulum-associated protein degradation pathway to enter the cytosol of yeast. FEBS Lett. 1999, 459, 80–84, doi:10.1016/S0014-5793(99)01222-3.
[130]
Li, S.; Spooner, R.A.; Allen, S.C.; Guise, C.P.; Ladds, G.; Schnoder, T.; Schmitt, M.J.; Lord, J.M.; Roberts, L.M. Folding-competent and folding-defective forms of ricin A chain have different fates after retrotranslocation from the endoplasmic reticulum. Mol. Biol. Cell 2010, 21, 2543–2554, doi:10.1091/mbc.E09-08-0743.
[131]
Keusch, G.T.; Jacewicz, M.; Acheson, D.W.; Donohue-Rolfe, A.; Kane, A.V.; McCluer, R.H. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect. Immun. 1995, 63, 1138–1141.
[132]
Nakanishi, K.; Kamiguchi, K.; Torigoe, T.; Nabeta, C.; Hirohashi, Y.; Asanuma, H.; Tobioka, H.; Koge, N.; Harada, O.; Tamura, Y.; Nagano, H.; Yano, S.; Chiba, S.; Matsumoto, H.; Sato, N. Localization and function in endoplasmic reticulum stress tolerance of ERdj3, a new member of Hsp40 family protein. Cell Stress Chaperones 2004, 9, 253–264, doi:10.1379/CSC-52.1.
[133]
Yu, M.; Haslam, R.H.; Haslam, D.B. HEDJ, an Hsp40 co-chaperone localized to the endoplasmic reticulum of human cells. J. Biol. Chem. 2000, 275, 24984–24992, doi:10.1074/jbc.M000739200.
[134]
Yu, M.; Haslam, D.B. Shiga toxin is transported from the endoplasmic reticulum following interaction with the luminal chaperone HEDJ/ERdj3. Infect. Immun. 2005, 73, 2524–2532, doi:10.1128/IAI.73.4.2524-2532.2005.
[135]
Li, S.; Spooner, R.A.; Hampton, R.Y.; Lord, J.M.; Roberts, L.M. Cytosolic entry of Shiga-like toxin a chain from the yeast endoplasmic reticulum requires catalytically active Hrd1p. PLoS One 2012, 7, e41119.
[136]
Koopmann, J.O.; Albring, J.; Huter, E.; Bulbuc, N.; Spee, P.; Neefjes, J.; Hammerling, G.J.; Momburg, F. Export of antigenic peptides from the endoplasmic reticulum intersects with retrograde protein translocation through the Sec61p channel. Immunity 2000, 13, 117–127, doi:10.1016/S1074-7613(00)00013-3.
[137]
Schauble, N.; Cavalie, A.; Zimmermann, R.; Jung, M. Interaction of Pseudomonas aeruginosa Exotoxin A with the human Sec61 complex suppresses passive calcium efflux from the endoplasmic reticulum. Channels (Austin) 2013, 8, doi:10.4161/chan.26526.
[138]
Murayama, T.; Tsai, S.C.; Adamik, R.; Moss, J.; Vaughan, M. Effects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity. Biochemistry 1993, 32, 561–566, doi:10.1021/bi00053a022.
[139]
Raasi, S.; Wolf, D.H. Ubiquitin receptors and ERAD: a network of pathways to the proteasome. Semin. Cell Dev. Biol. 2007, 18, 780–791, doi:10.1016/j.semcdb.2007.09.008.
[140]
Bar-Nun, S. The role of p97/Cdc48p in endoplasmic reticulum-associated degradation: from the immune system to yeast. Curr. Top. Microbiol. Immunol. 2005, 300, 95–125.
[141]
Carlson, E.J.; Pitonzo, D.; Skach, W.R. p97 functions as an auxiliary factor to facilitate TM domain extraction during CFTR ER-associated degradation. EMBO J. 2006, 25, 4557–4566, doi:10.1038/sj.emboj.7601307.
[142]
Nowis, D.; McConnell, E.; Wojcik, C. Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates. Exp. Cell Res. 2006, 312, 2921–2932, doi:10.1016/j.yexcr.2006.05.013.
[143]
Wojcik, C.; Rowicka, M.; Kudlicki, A.; Nowis, D.; McConnell, E.; Kujawa, M.; DeMartino, G.N. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol. Biol. Cell 2006, 17, 4606–4618, doi:10.1091/mbc.E06-05-0432.
[144]
Abujarour, R.J.; Dalal, S.; Hanson, P.I.; Draper, R.K. p97 is in a complex with cholera toxin and influences the transport of cholera toxin and related toxins to the cytoplasm. J. Biol. Chem. 2005, 280, 15865–15871, doi:10.1074/jbc.M406316200.
[145]
Kothe, M.; Ye, Y.; Wagner, J.S.; De Luca, H.E.; Kern, E.; Rapoport, T.A.; Lencer, W.I. Role of p97 AAA-ATPase in the retrotranslocation of the cholera toxin A1 chain, a non-ubiquitinated substrate. J. Biol. Chem. 2005, 280, 28127–28132, doi:10.1074/jbc.M503138200.
[146]
McConnell, E.; Lass, A.; Wojcik, C. Ufd1-Npl4 is a negative regulator of cholera toxin retrotranslocation. Biochem. Biophys. Res. Commun. 2007, 355, 1087–1090, doi:10.1016/j.bbrc.2007.02.077.
[147]
Rodighiero, C.; Tsai, B.; Rapoport, T.A.; Lencer, W.I. Role of ubiquitination in retro-translocation of cholera toxin and escape of cytosolic degradation. EMBO Rep. 2002, 3, 1222–1227, doi:10.1093/embo-reports/kvf239.
[148]
Marshall, R.S.; Jolliffe, N.A.; Ceriotti, A.; Snowden, C.J.; Lord, J.M.; Frigerio, L.; Roberts, L.M. The role of CDC48 in the retro-translocation of non-ubiquitinated toxin substrates in plant cells. J. Biol. Chem. 2008, 283, 15869–15877, doi:10.1074/jbc.M709316200.
[149]
Lipson, C.; Alalouf, G.; Bajorek, M.; Rabinovich, E.; Atir-Lande, A.; Glickman, M.; Bar-Nun, S. A proteasomal ATPase contributes to dislocation of endoplasmic reticulum-associated degradation (ERAD) substrates. J. Biol. Chem. 2008, 283, 7166–7175, doi:10.1074/jbc.M705893200.
[150]
Lee, R.J.; Liu, C.W.; Harty, C.; McCracken, A.A.; Latterich, M.; Romisch, K.; DeMartino, G.N.; Thomas, P.J.; Brodsky, J.L. Uncoupling retro-translocation and degradation in the ER-associated degradation of a soluble protein. EMBO J. 2004, 23, 2206–2215, doi:10.1038/sj.emboj.7600232.
Finley, D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu. Rev. Biochem. 2009, 78, 477–513, doi:10.1146/annurev.biochem.78.081507.101607.
[153]
London, E.; Luongo, C.L. Domain-specific bias in arginine/lysine usage by protein toxins. Biochem. Biophys. Res. Commun. 1989, 160, 333–339, doi:10.1016/0006-291X(89)91660-4.
[154]
Hazes, B.; Read, R.J. Accumulating evidence suggests that several AB-toxins subvert the endoplasmic reticulum-associated protein degradation pathway to enter target cells. Biochemistry 1997, 36, 11051–11054, doi:10.1021/bi971383p.
[155]
Burnette, W.N.; Mar, V.L.; Platler, B.W.; Schlotterbeck, J.D.; McGinley, M.D.; Stoney, K.S.; Rohde, M.F.; Kaslow, H.R. Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activity. Infect. Immun. 1991, 59, 4266–4270.
[156]
Wernick, N.L.; De Luca, H.; Kam, W.R.; Lencer, W.I. N-terminal Extension of the cholera toxin A1-chain causes rapid degradation after retrotranslocation from endoplasmic reticulum to cytosol. J. Biol. Chem. 2010, 285, 6145–6152, doi:10.1074/jbc.M109.062067.
[157]
Teter, K.; Allyn, R.L.; Jobling, M.G.; Holmes, R.K. Transfer of the cholera toxin A1 polypeptide from the endoplasmic reticulum to the cytosol is a rapid process facilitated by the endoplasmic reticulum-associated degradation pathway. Infect. Immun. 2002, 70, 6166–6171, doi:10.1128/IAI.70.11.6166-6171.2002.
[158]
Teter, K.; Jobling, M.G.; Sentz, D.; Holmes, R.K. The cholera toxin A13 subdomain is essential for interaction with ADP-ribosylation factor 6 and full toxic activity but is not required for translocation from the endoplasmic reticulum to the cytosol. Infect. Immun. 2006, 74, 2259–2267, doi:10.1128/IAI.74.4.2259-2267.2006.
[159]
Di Cola, A.; Frigerio, L.; Lord, J.M.; Ceriotti, A.; Roberts, L.M. Ricin A chain without its partner B chain is degraded after retrotranslocation from the endoplasmic reticulum to the cytosol in plant cells. Proc. Natl. Acad. Sci. USA 2001, 98, 14726–14731, doi:10.1073/pnas.251386098.
[160]
Di Cola, A.; Frigerio, L.; Lord, J.M.; Roberts, L.M.; Ceriotti, A. Endoplasmic reticulum-associated degradation of ricin A chain has unique and plant-specific features. Plant Physiology 2005, 137, 287–296, doi:10.1104/pp.104.055434.
[161]
Frigerio, L.; Vitale, A.; Lord, J.M.; Ceriotti, A.; Roberts, L.M. Free ricin A chain, proricin, and native toxin have different cellular fates when expressed in tobacco protoplasts. J. Biol. Chem. 1998, 273, 14194–14199, doi:10.1074/jbc.273.23.14194.
[162]
Pietroni, P.; Vasisht, N.; Cook, J.P.; Roberts, D.M.; Lord, J.M.; Hartmann-Petersen, R.; Roberts, L.M.; Spooner, R.A. The proteasome cap RPT5/Rpt5p subunit prevents aggregation of unfolded ricin A chain. Biochem. J. 2013, 453, 435–445, doi:10.1042/BJ20130133.
[163]
Heinemeyer, W.; Kleinschmidt, J.A.; Saidowsky, J.; Escher, C.; Wolf, D.H. Proteinase yscE, the yeast proteasome/multicatalytic-multifunctional proteinase: mutants unravel its function in stress induced proteolysis and uncover its necessity for cell survival. EMBO J. 1991, 10, 555–562.
[164]
Worthington, Z.E.; Carbonetti, N.H. Evading the proteasome: absence of lysine residues contributes to pertussis toxin activity by evasion of proteasome degradation. Infect. Immun. 2007, 75, 2946–2953, doi:10.1128/IAI.02011-06.
[165]
Taylor, M.; Banerjee, T.; VanBennekom, N.; Teter, K. Detection of toxin translocation into the host cytosol by surface plasmon resonance. J. Vis. Exp. 2012, 59, doi:10.3791/3686.
[166]
Banerjee, T.; Cilenti, L.; Showman, A.; Taylor, M.; Tatulian, S.A.; Teter, K. Thermal unfolding of the pertussis toxin S1 subunit facilitates toxin translocation to the cytosol by the mechanism of endoplasmic reticulum-associated degradationManuscript in preparation.
[167]
Tam, P.J.; Lingwood, C.A. Membrane cytosolic translocation of verotoxin A1 subunit in target cells. Microbiology 2007, 153, 2700–2710, doi:10.1099/mic.0.2007/006858-0.
[168]
Ray, S.; Taylor, M.; Banerjee, T.; Tatulian, S.A.; Teter, K. Lipid rafts alter the stability and activity of the cholera toxin A1 subunit. J. Biol. Chem. 2012, 287, 30395–30405, doi:10.1074/jbc.M112.385575.
[169]
Welsh, C.F.; Moss, J.; Vaughan, M. ADP-ribosylation factors: a family of approximately 20-kDa guanine nucleotide-binding proteins that activate cholera toxin. Mol. Cell. Biochem. 1994, 138, 157–166, doi:10.1007/BF00928458.
[170]
Banerjee, T.; Taylor, M.; Jobling, M.G.; Burress, H.; Serrano, A.; Yang, Z.; Holmes, R.K.; Tatulian, S.A.; Teter, K. ADP-ribosylation factor 6 acts as an allosteric activator for the folded but not disordered cholera toxin A1 polypeptideManuscript in preparation.
[171]
Burress, H.; Taylor, M.; Banerjee, T.; Tatulian, S.A.; Teter, K. Co- and post-translocation roles for Hsp90 in cholera intoxicationManuscript in preparation.
[172]
Murayama, T.; Hewlett, E.L.; Maloney, N.J.; Justice, J.M.; Moss, J. Effect of temperature and host factors on the activities of pertussis toxin and Bordetella adenylate cyclase. Biochemistry 1994, 33, 15293–15297, doi:10.1021/bi00255a010.
[173]
Devin, A.; Nogueira, V.; Leverve, X.; Guerin, B.; Rigoulet, M. Allosteric activation of pyruvate kinase via NAD+ in rat liver cells. Eur. J. Biochem. 2001, 268, 3943–3949, doi:10.1046/j.1432-1327.2001.02306.x.
[174]
Uversky, V.N.; Oldfield, C.J.; Dunker, A.K. Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu. Rev. Biophys. 2008, 37, 215–246, doi:10.1146/annurev.biophys.37.032807.125924.
